VivoPower Believes It Meets Nasdaq Equity Requirement Following Reg S Investment

Stock Information for AnPac Bio-Medical Science Co. Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AnPac Bio-Medical Science Co. Ltd.

VivoPower Executes $300 Million Definitive Joint Venture Agreement with South Korea-Based Lean Ventures to Acquire and Hold Ripple Labs Shares
VivoPower Enters Heads of Agreement with KOSDAQ Listed KWeather to Launch Initial US$5 Million XRP Focused Digital Asset Reserve & WeatherCoin Tokenization Project in South Korea 
VivoPower's Tembo to Accelerate Africa Expansion in Definitive Agreement with AVA, East Africa's Largest Vehicle Assembler
VivoPower Closes Additional $19 Million Equity Raise Priced at $6.05 Per Share, a Premium to Market
VivoPower Establishes South Korean Office and Appoints Local Representative Director
VivoPower to Procure XRP at up to 65% Discount by Exchanging Mined Tokens from Expanded Digital Asset Mining Fleet
VivoPower's Tembo to Accept Ripple USD (RLUSD) Stablecoin for Payments
VivoPower Partners with Doppler Finance for Institutional XRP and RLUSD Yield Programs: Maximizing Returns on Crypto Treasury Strategy

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.